| Literature DB >> 21338499 |
Jorrit Boekel1, Orjan Källskog, Monica Rydén-Aulin, Mikael Rhen, Agneta Richter-Dahlfors.
Abstract
BACKGROUND: Mucosal infections elicit inflammatory responses via regulated signaling pathways. Infection outcome depends strongly on early events occurring immediately when bacteria start interacting with cells in the mucosal membrane. Hitherto reported transcription profiles on host-pathogen interactions are strongly biased towards in vitro studies. To detail the local in vivo genetic response to infection, we here profiled host gene expression in a recent experimental model that assures high spatial and temporal control of uropathogenic Escherichia coli (UPEC) infection within the kidney of a live rat.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21338499 PMCID: PMC3047304 DOI: 10.1186/1471-2164-12-123
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Bacterial growth and tissue response within the first 8 h post-infection. Proximal tubule of rat kidney infected by UPEC. A-C. Imaging by two-photon microscopy of infected kidney 3 h (A), 5 h (B), and 8 h (C) post-infection. Bacteria are shown in green, blood flow is labelled with red dextran, injected tubules are visualized by endocytosed blue dextran. Scale bar 30 μm. D. Relative expression of gfp+ by bacteria quantified by qRT-PCR. Measurements are normalized to the 3 h time point. ND - not detected. Error bars show SD, n = 3. E-G. Gene expression 3 h (E), 5 h (F), and 8 h (G) post-infection quantified by microarray. Each point represents one array probe, n = 3. Probes marked in red have adjusted P-values of <0.59 (E), <0.15 (F), and <0.05 (G).
Amount of probes or genes differentially expressed at different thresholds
| Data set | pa < 0.05 | p < 0.05 & |fold exp|>2 | p < 0.5 | Bb>-2.5 | ||||
|---|---|---|---|---|---|---|---|---|
| probes | genes | probes | genes | probes | genes | probes | genes | |
| 3 h post-infection | 0 | 0 | 0 | 0 | - | - | - | - |
| 5 h post-infection | 0 | 0 | 0 | 0 | - | - | 368 | - |
| 8 h post-infection | 113 | -c | 76 | 59 | 458 | 341 | 386 | - |
| Study | - | - | 81 | 61 | 11208 | - | 1480 | - |
| Study | - | - | 86 | 71 | 569 | - | 722 | - |
| Study | - | - | 363 | 265 | 11961 | - | 3660 | - |
a Adjusted P-value
b Bayes statistic
c not determined
d For reference see Table 2
Figure 2Clustering of differentially expressed host genes into functionally defined categories. GO annotations of differentially expressed genes identified at 8 h post-infection were analyzed and visualized in a directed acyclic graph using the BINGO plugin in Cytoscape. Categories are shown as circles, the diameter corresponding to the amount of found genes in a category. The adjusted P-value for overrepresentation of differentially expressed genes was calculated for each category and color coded, white circles have no overrepresentation. Circles marked GO represent the root node of gene ontology categories and contain all found genes. A. Genes retrieved with the criteria adjusted P-value <0.05 and differential expression ≥2. The numbering corresponds to the numbers in B. B. Genes retrieved with the criterion adjusted P-value <0.5. Numbering represents GO categories, see supporting information S4. The left half of the graph includes all numbered categories in Figure 2A, the right half comprises categories involved in biological regulation.
Microarray data sets analyzed in this study
| Study | Animal | Organ | Agent | Delivery | Challenge time (h) | Reference |
|---|---|---|---|---|---|---|
| Rat | Kidney | Tubular injection | 8 | E-MEXP-2136 This work | ||
| Mouse | Brain | LPS | Intraparenchymal | 12 | E-GEOD-6509 [ | |
| Mouse | Brain | LPS | Intracerebroventricular | 6 | E-MEXP-420 [ | |
| Mouse | Lung | LPS | Aerosol inhalation | 4 | E-GEOD-2411 [ |
Figure 3Commonly upregulated genes during early local inflammation. A. Hierarchical clustering of differentially expressed genes (rows) from studies a-d (columns) (Table 2). Yellow represents differentially expressed genes, while blue are non-differentially expressed. Genes differentially expressed in all datasets are shown in text. B and C. Genes in each study were ranked after adjusted P-value (B) or Bayes statistic (C), the rank number was plotted against adjusted P-value (B) and Bayes statistic (C). Study a - green, b - blue, c - red, and d - black. The dashed horizontal line shows an adjusted P-value of 0.5 (B) or a Bayes statistic of -2.5 (C). D. Gene names in all four studies were replaced with random names. Amounts of differentially expressed genes present in all four studies were plotted against Bayes statistic threshold. Error bars show SD of 20 randomized trials. E. Venn diagram showing the relationship between probes differentially expressed (Bayes statistc ≥-2.5) at 8 h (orange) and 5 h (green), respectively. The purple circle represents probes differentially expressed 8 h post-infection with adjusted P-value <0.05 and fold expression >2. Amounts of probes are given. F. Relative expression levels of core genes quantified by qRT-PCR. Expression levels in UPEC- (white bars) and PBS -injected tissue were normalized to that of PBS injected-tissue. *indicate a P-value <0.05 defined by Student's t-test between PBS and UPEC injected samples, # indicate a P-value <0.10. Error bars show SD, n = 3.
Core of commonly expressed genes 8 h post-infection
| Gene | Function |
|---|---|
| serine (or cysteine) peptidase inhibitor, clade E, member 1 | |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |
| 2'-5' oligoadenylate synthetase-like 1 | |
| interferon-induced protein 44 | |
| chemokine (C-X-C motif) ligand 2 | |
| TRAF-interacting protein with forkhead-associated domain | |
| chemokine (C-C motif) ligand 3 | |
| selectin, platelet | |
| zinc finger protein 36 | |
| interferon regulatory factor 7 | |
| interferon activated gene 205 | |
| baculoviral IAP repeat-containing 3 | |
| myeloid differentiation primary response gene 88 | |
| chemokine (C-C motif) ligand 19 | |
| suppressor of cytokine signaling 3 | |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | |
| immediate early response 3 | |
| 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | |
| chemokine (C-C motif) ligand 4 | |
| pentraxin related gene | |
| interleukin 1 beta | |
| GLI pathogenesis-related 2 | |
| AT rich interactive domain 5A (Mrf1 like) | |
| chemokine (C-X-C motif) ligand 10 | |
| interferon-induced protein with tetratricopeptide repeats 3 | |
| chemokine (C-X-C motif) ligand 1 | |
| immunoresponsive gene 1 | |
| growth arrest and DNA-damage-inducible 45 beta | |
| poly (ADP-ribose) polymerase family, member 14 | |
| serine (or cysteine) peptidase inhibitor, clade A, member 3N | |
| interferon gamma inducible protein 47 | |
| interleukin 1 receptor antagonist | |
| regulator of G-protein signaling 16 | |
| interleukin 6 | |
| A kinase (PRKA) anchor protein (gravin) 12 | |
| uridine phosphorylase 1 | |
| intercellular adhesion molecule 1 | |
| solute carrier family 15, member 3 | |
| transmembrane protein 2 | |
| 2'-5' oligoadenylate synthetase 1G | |
| superoxide dismutase 2, mitochondrial | |
| interferon induced with helicase C domain 1 | |
| cDNA sequence BC006779 | |
| STEAP family member 4 | |
| poly (ADP-ribose) polymerase family, member 9 | |
| schlafen 4 | |
| tissue inhibitor of metalloproteinase 1 | |
| pleckstrin | |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 | |
| prostaglandin E synthase | |
| receptor (TNFRSF)-interacting serine-threonine kinase 2 | |
| CASP8 and FADD-like apoptosis regulator | |
| CCAAT/enhancer binding protein (C/EBP), beta | |
| chemokine (C-X-C motif) ligand 11 | |
| regulator of calcineurin 1 | |
| hexokinase 2 | |
| chemokine (C-C motif) ligand 2 | |
| poliovirus receptor | |
| CD274 antigen | |
| tubulin, beta 6 | |
| cholesterol 25-hydroxylase | |
| interferon regulatory factor 1 | |
| solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 | |
| tribbles homolog 1 (Drosophila) | |
| vascular cell adhesion molecule 1 | |
| phosphodiesterase 4B, cAMP specific | |
| S100 calcium binding protein A9 (calgranulin B) | |
| proteasome (prosome, macropain) 28 subunit, beta | |
| proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) | |
| lipocalin 2 | |
| lymphocyte cytosolic protein 1 | |
| cyclin-dependent kinase inhibitor 1A (P21) | |
| ceruloplasmin | |
| prostaglandin-endoperoxide synthase 2 | |
| proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) | |
| hemopoietic cell kinase | |
| leukemia inhibitory factor | |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, p105 | |
| chemokine (C-X-C motif) ligand 9 | |
| signal transducer and activator of transcription 1 |
*Genes induced by IFN-γ
Core of commonly expressed genes 5 h post-infection
| Gene | Function |
|---|---|
| 2'-5' oligoadenylate synthetase-like 1 | |
| chemokine (C-X-C motif) ligand 2 | |
| chemokine (C-C motif) ligand 3 | |
| myxovirus (influenza virus) resistance 1 | |
| interferon regulatory factor 7 | |
| v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) | |
| baculoviral IAP repeat-containing 3 | |
| cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial | |
| chemokine (C-X-C motif) ligand 10 | |
| interferon-induced protein with tetratricopeptide repeats 3 | |
| chemokine (C-X-C motif) ligand 1 | |
| poly (ADP-ribose) polymerase family, member 14 | |
| serine (or cysteine) peptidase inhibitor, clade A, member 3N | |
| interleukin 1 receptor antagonist | |
| intercellular adhesion molecule 1 | |
| solute carrier family 15, member 3 | |
| 2'-5' oligoadenylate synthetase 1G | |
| tumor necrosis factor receptor superfamily, member 12a | |
| poly (ADP-ribose) polymerase family, member 9 | |
| schlafen 4 | |
| tissue inhibitor of metalloproteinase 1 | |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 | |
| receptor (TNFRSF)-interacting serine-threonine kinase 2 | |
| chemokine (C-X-C motif) ligand 11 | |
| promyelocytic leukemia | |
| interferon regulatory factor 1 | |
| tribbles homolog 1 (Drosophila) | |
| S100 calcium binding protein A9 (calgranulin B) | |
| chemokine (C-C motif) ligand 7 | |
| prostaglandin-endoperoxide synthase 2 | |
| leukemia inhibitory factor |
Figure 4IFN-γ responses to early infection. UPEC or PBS were injected into rat kidney proximal tubules. A. Ratio of IFN-γ concentration at 8 h relative to 0 h, measured by ELISA, in serum from PBS or UPEC injected animals. * P-value <0.05 defined by a Student's t-test between PBS and UPEC injected animals log-transformed ratios of IFN-γ concentrations at 8 h to 0 h. B-D. Relative expression of different genes in spleen and kidney measured by qRT-PCR 8 h post-infection. Expression levels in UPEC (white bars) and PBS samples were normalized to that of PBS samples. * P-value <0.05 defined by Student's t-test between samples from PBS- and UPEC-injected animals. Gene expression in spleen tissue (B), kidney tissue that has been injected with UPEC or PBS (C), and naïve kidney tissue located ~1 cm from the injected site (D). In all panels, error bars show SD, n = 3.